» Articles » PMID: 34171285

Reprogramming Astrocytes to Motor Neurons by Activation of Endogenous Ngn2 and Isl1

Overview
Publisher Cell Press
Specialty Cell Biology
Date 2021 Jun 25
PMID 34171285
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Central nervous system injury and neurodegenerative diseases cause irreversible loss of neurons. Overexpression of exogenous specific transcription factors can reprogram somatic cells into functional neurons for regeneration and functional reconstruction. However, these practices are potentially problematic due to the integration of vectors into the host genome. Here, we showed that the activation of endogenous genes Ngn2 and Isl1 by CRISPRa enabled reprogramming of mouse spinal astrocytes and embryonic fibroblasts to motor neurons. These induced neurons showed motor neuronal morphology and exhibited electrophysiological activities. Furthermore, astrocytes in the spinal cord of the adult mouse can be converted into motor neurons by this approach with high efficiency. These results demonstrate that the activation of endogenous genes is sufficient to induce astrocytes into functional motor neurons in vitro and in vivo. This direct neuronal reprogramming approach may provide a novel potential therapeutic strategy for treating neurodegenerative diseases and spinal cord injury.

Citing Articles

Development of artificial transcription factors and their applications in cell reprograming, genetic screen, and disease treatment.

Sang Y, Xu L, Bao Z Mol Ther. 2024; 32(12):4208-4234.

PMID: 39473180 PMC: 11638881. DOI: 10.1016/j.ymthe.2024.10.029.


On RNA-programmable gene modulation as a versatile set of principles targeting muscular dystrophies.

Capelletti S, Garcia Soto S, Goncalves M Mol Ther. 2024; 32(11):3793-3807.

PMID: 39169620 PMC: 11573585. DOI: 10.1016/j.ymthe.2024.08.016.


Neuronal repair after spinal cord injury by in vivo astrocyte reprogramming mediated by the overexpression of NeuroD1 and Neurogenin-2.

Talifu Z, Zhang C, Xu X, Pan Y, Ke H, Li Z Biol Res. 2024; 57(1):53.

PMID: 39135103 PMC: 11318173. DOI: 10.1186/s40659-024-00534-w.


Decoding single-cell molecular mechanisms in astrocyte-to-iN reprogramming via Ngn2- and Pax6-mediated direct lineage switching.

Qin R, Zhang Y, Yang Y, Chen J, Huang L, Xu W Eur J Med Res. 2024; 29(1):390.

PMID: 39068473 PMC: 11282629. DOI: 10.1186/s40001-024-01989-z.


A promise for neuronal repair: reprogramming astrocytes into neurons in vivo.

Huang L, Lai X, Liang X, Chen J, Yang Y, Xu W Biosci Rep. 2024; 44(1).

PMID: 38175538 PMC: 10830445. DOI: 10.1042/BSR20231717.


References
1.
Knoepfler P . Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells. 2009; 27(5):1050-6. PMC: 2733374. DOI: 10.1002/stem.37. View

2.
Zalatan J, Lee M, Almeida R, Gilbert L, Whitehead E, La Russa M . Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell. 2014; 160(1-2):339-50. PMC: 4297522. DOI: 10.1016/j.cell.2014.11.052. View

3.
Xu Z, Jiang H, Zhong P, Yan Z, Chen S, Feng J . Direct conversion of human fibroblasts to induced serotonergic neurons. Mol Psychiatry. 2015; 21(1):62-70. PMC: 4518549. DOI: 10.1038/mp.2015.101. View

4.
Drouin-Ouellet J, Pircs K, Barker R, Jakobsson J, Parmar M . Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned?. Front Neurosci. 2017; 11:530. PMC: 5625013. DOI: 10.3389/fnins.2017.00530. View

5.
Fehlings M, Tetreault L, Wilson J, Kwon B, Burns A, Martin A . A Clinical Practice Guideline for the Management of Acute Spinal Cord Injury: Introduction, Rationale, and Scope. Global Spine J. 2017; 7(3 Suppl):84S-94S. PMC: 5684846. DOI: 10.1177/2192568217703387. View